Jennison Associates’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-43,181
| Closed | -$563K | – | 610 |
|
|
2022
Q3 | $563K | Sell |
43,181
-553
| -1% | -$7.21K | ﹤0.01% | 576 |
|
|
2022
Q2 | $554K | Sell |
43,734
-21
| -0% | -$266 | ﹤0.01% | 592 |
|
|
2022
Q1 | $613K | Sell |
43,755
-867,249
| -95% | -$12.2M | ﹤0.01% | 607 |
|
|
2021
Q4 | $26.4M | Sell |
911,004
-8,215
| -0.9% | -$238K | 0.02% | 317 |
|
|
2021
Q3 | $27.5M | Buy |
919,219
+182
| +0% | +$5.45K | 0.02% | 323 |
|
|
2021
Q2 | $24.4M | Sell |
919,037
-957
| -0.1% | -$25.4K | 0.02% | 345 |
|
|
2021
Q1 | $28.6M | Buy |
919,994
+721,743
| +364% | +$22.4M | 0.02% | 305 |
|
|
2020
Q4 | $6.52M | Sell |
198,251
-1,909
| -1% | -$62.8K | ﹤0.01% | 436 |
|
|
2020
Q3 | $6.99M | Buy |
+200,160
| New | +$6.99M | 0.01% | 407 |
|